상지 임플란트 시장 규모, 점유율, 동향 분석 보고서 : 지역별, 부문별 예측(2024-2030년)

Upper Extremity Implants Market Growth & Trends:

The global upper extremity implants market size is anticipated to reach USD 2.28 billion by 2030 and is projected to grow at a CAGR of 4.0% during the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of musculoskeletal disorders significantly influences the upper extremity implant market. Conditions such as arthritis, tendonitis, and osteoporosis are becoming more common, particularly among the aging population. According to a WHO report from July 2022, around 1.71 billion people globally suffer from musculoskeletal conditions.

These disorders often lead to impaired mobility and chronic pain, necessitating medical intervention and, in severe cases, surgical procedures involving implants. The growing awareness of these conditions and the availability of advanced diagnostic tools enable earlier detection and treatment, further driving the demand for upper extremity implants. As the global population ages, the incidence of musculoskeletal disorders is expected to increase, ensuring a steady demand for implant solutions designed to restore function and improve the quality of life for affected individuals.

Companies such as Zimmer Biomet, Stryker, Johnson & Johnson, and Smith+Nephew are at the forefront of introducing innovative implant solutions and advanced surgical techniques. Technological advancements like 3D printing, robotics, and biocompatible materials are enhancing the precision, durability, and functionality of implants, leading to improved patient outcomes and reduced recovery times. For instance, in August 2022, OSSIO, Inc. announced the launch and initial commercial use of OSSIOfiber Anchors.

This introduction expands patient access to OSSIO's growing portfolio of bio-integrative implants, which are designed for use in shoulder, hand/wrist, and elbow surgeries. These innovations enable the development of customized implants tailored to individual patient needs, increasing the adoption of these devices. The continuous efforts of these key players to innovate and improve implant technology are pivotal in driving the expansion and the market evolution.

Furthermore, the increasing participation in sports and physical activities has led to a higher incidence of sports-related injuries, which in turn drives the demand for upper extremity implants. Injuries such as fractures, dislocations, and ligament tears are common among athletes and active individuals, often requiring surgical intervention to restore functionality. The growing awareness of the benefits of early and effective treatment for sports injuries has prompted more individuals to seek medical help, leading to an increase in the number of surgical procedures involving implants. Moreover, advancements in minimally invasive surgical techniques and improved implant designs have made these procedures more effective and accessible, further fueling market growth.

Upper Extremity Implants Market Report Highlights:

• The shoulder segment held the largest share of 59.52% in 2023. The segment's growth is propelled by a rise in sports injuries, shoulder dislocations, a growing geriatric population, increasing incidence of osteoarthritis, shoulder fractures, accidents, and traumas, all contributing to higher demand for upper extremity implant products
• The metallic biomaterials segment held the largest share in 2023. This can be attributed to advanced properties such as proper strength, fracture toughness, ductility, hardness, corrosion resistance, and biocompatibility
• The hospitals segment held the largest share in 2023. Innovations such as robotic-assisted surgery and advanced imaging techniques enhance surgical accuracy and patient outcomes
• North America market dominated the overall global market in 2023. Factors such as rising common shoulder injuries such as include dislocations/separations, sprains/strains, contusions, and fractures. The rise in the geriatric population, increasing number of sports injuries, and presence of key participants in North America are driving regional growth
• The competitive scenario in the market is highly competitive, with key players holding significant positions. The major companies are undertaking various strategies such as new product development, collaborations, acquisitions, mergers, and regional expansion to serve the unmet needs of their customers

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Biomaterial
  • 1.2.3. End Use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Biomaterial outlook
  • 2.2.3. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Upper Extremity Implants Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Upper Extremity Implants Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Upper Extremity Implants Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Upper Extremity Implants Market: Type Movement Analysis
• 4.3. Upper Extremity Implants Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
• 4.5. Shoulder
  • 4.5.1. Shoulder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Elbow
  • 4.6.1. Elbow Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Hand & Wrist
  • 4.7.1. Hand & Wrist Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Upper Extremity Implants Market: Biomaterial Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Upper Extremity Implants Market: Biomaterial Movement Analysis
• 5.3. Upper Extremity Implants Market by Biomaterial Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
• 5.5. Metallic Biomaterials
  • 5.5.1. Metallic Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Ceramic Biomaterials
  • 5.6.1. Ceramic Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Polymeric Biomaterials
  • 5.7.1. Polymeric Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Natural Biomaterials
  • 5.8.1. Natural Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Upper Extremity Implants Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Upper Extremity Implants Market: End Use Movement Analysis
• 6.3. Upper Extremity Implants Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. ASCs
  • 6.6.1. ASCs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Clinics
  • 6.7.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Upper Extremity Implants Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Upper Extremity Implants Market movement analysis
• 7.3. Upper Extremity Implants Market: Regional Estimates & Trend Analysis by Type, Biomaterial & End-use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
• 7.5. North America
  • 7.5.1. North America Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. U.S. Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Canada Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. UK Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Germany Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. France Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Italy Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Spain Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Denmark Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.8. Norway
    • 7.6.8.1. Norway Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.9. Sweden
    • 7.6.9.1. Sweden Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Japan Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. China Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. India Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. South Korea Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Australia Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Thailand Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Brazil Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Argentina Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. Mexico
    • 7.8.4.1. Mexico Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. South Africa Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Saudi Arabia Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. UAE Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Kuwait Upper Extremity Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Stryker
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. DePuy
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Zimmer Biomet
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Smith & Nephew
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Medtronic
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Aesculap
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. BioTek Instruments
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. CONMED
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Arthrex, Inc.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Ossur
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. DJO Global
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Acumed LLC
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Product benchmarking
    • 8.2.12.4. Strategic initiatives